Clinical trials
Completed Supranuclear Palsy, Progressive trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Europea di Ricerca Biomedica Ferb Onlus | 2 |
| IRCCS San Raffaele Roma | 2 |
| Baylor College of Medicine | 1 |
| Centre Hospitalier Universitaire de la Guadeloupe | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Lahey Clinic | 1 |
| NYU Langone Health | 1 |
| Nantes University Hospital | 1 |
| Noscira SA | 1 |
| Ospedale Generale Di Zona Moriggia-Pelascini | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Supranuclear Palsy, Progressive | 18 |
| Parkinson Disease | 7 |
| Multiple System Atrophy | 5 |
| Corticobasal Degeneration | 4 |
| Lewy Body Disease | 4 |
| Parkinsonian Disorders | 4 |
| Dementia, Vascular | 2 |
| Frontotemporal Dementia | 2 |
| Alzheimer Disease | 1 |
| Aphasia, Primary Progressive | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.